Cargando…

Assessing the Economic Burden and Benefit-cost of Treating Attention-deficit Hyperactivity Disorder in Germany

Background: Attention-deficit hyperactivity disorder (ADHD) is a condition which has been consistently documented to impact educational outcomes. Children with ADHD are regularly found to have lower educational attainment and increased likelihood of dropping out of school compared to children withou...

Descripción completa

Detalles Bibliográficos
Autores principales: Kotsopoulos, Nikolaos, Connolly, Mark P., Sobanski, Esther, Postma, Maarten J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Columbia Data Analytics, LLC 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10471420/
https://www.ncbi.nlm.nih.gov/pubmed/37662879
_version_ 1785099847793115136
author Kotsopoulos, Nikolaos
Connolly, Mark P.
Sobanski, Esther
Postma, Maarten J.
author_facet Kotsopoulos, Nikolaos
Connolly, Mark P.
Sobanski, Esther
Postma, Maarten J.
author_sort Kotsopoulos, Nikolaos
collection PubMed
description Background: Attention-deficit hyperactivity disorder (ADHD) is a condition which has been consistently documented to impact educational outcomes. Children with ADHD are regularly found to have lower educational attainment and increased likelihood of dropping out of school compared to children without ADHD. Objectives: To project the long-term societal economic consequences of reduced educational attainment, as measured by total lifetime earnings, in an untreated cohort of individuals diagnosed with ADHD in childhood, in Germany. In addition, this research aims at illustrating a cost-benefit analysis framework which could be applied to economically appraise the rate of return from investments in hypothetical health interventions targeting ADHD. Methods: Observational ADHD evidence was collated with demographic and human capital economics methods to quantify ADHD’s impact on educational attainment and long-term labour outcome in Germany. The theoretical benefits deriving from effective interventions targeting ADHD were also quantified. Results: It was estimated that the average per capita lifetime earning loss associated with ADHD was €92,000 suggesting a societal loss of €2.93 billion from a single cohort (n=31,864). The benefit-cost analysis suggested that reasonably effective intervention may justify considerable investment in ADHD targeted intervention. Conclusions: Considering the broad economic consequences of the condition might suggest that interventions which change the life course of individuals with ADHD could offer cost-savings and influence future economic outputs.
format Online
Article
Text
id pubmed-10471420
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Columbia Data Analytics, LLC
record_format MEDLINE/PubMed
spelling pubmed-104714202023-09-01 Assessing the Economic Burden and Benefit-cost of Treating Attention-deficit Hyperactivity Disorder in Germany Kotsopoulos, Nikolaos Connolly, Mark P. Sobanski, Esther Postma, Maarten J. J Health Econ Outcomes Res Psychological Conditions Background: Attention-deficit hyperactivity disorder (ADHD) is a condition which has been consistently documented to impact educational outcomes. Children with ADHD are regularly found to have lower educational attainment and increased likelihood of dropping out of school compared to children without ADHD. Objectives: To project the long-term societal economic consequences of reduced educational attainment, as measured by total lifetime earnings, in an untreated cohort of individuals diagnosed with ADHD in childhood, in Germany. In addition, this research aims at illustrating a cost-benefit analysis framework which could be applied to economically appraise the rate of return from investments in hypothetical health interventions targeting ADHD. Methods: Observational ADHD evidence was collated with demographic and human capital economics methods to quantify ADHD’s impact on educational attainment and long-term labour outcome in Germany. The theoretical benefits deriving from effective interventions targeting ADHD were also quantified. Results: It was estimated that the average per capita lifetime earning loss associated with ADHD was €92,000 suggesting a societal loss of €2.93 billion from a single cohort (n=31,864). The benefit-cost analysis suggested that reasonably effective intervention may justify considerable investment in ADHD targeted intervention. Conclusions: Considering the broad economic consequences of the condition might suggest that interventions which change the life course of individuals with ADHD could offer cost-savings and influence future economic outputs. Columbia Data Analytics, LLC 2013-11-12 /pmc/articles/PMC10471420/ /pubmed/37662879 Text en https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (4.0) (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Psychological Conditions
Kotsopoulos, Nikolaos
Connolly, Mark P.
Sobanski, Esther
Postma, Maarten J.
Assessing the Economic Burden and Benefit-cost of Treating Attention-deficit Hyperactivity Disorder in Germany
title Assessing the Economic Burden and Benefit-cost of Treating Attention-deficit Hyperactivity Disorder in Germany
title_full Assessing the Economic Burden and Benefit-cost of Treating Attention-deficit Hyperactivity Disorder in Germany
title_fullStr Assessing the Economic Burden and Benefit-cost of Treating Attention-deficit Hyperactivity Disorder in Germany
title_full_unstemmed Assessing the Economic Burden and Benefit-cost of Treating Attention-deficit Hyperactivity Disorder in Germany
title_short Assessing the Economic Burden and Benefit-cost of Treating Attention-deficit Hyperactivity Disorder in Germany
title_sort assessing the economic burden and benefit-cost of treating attention-deficit hyperactivity disorder in germany
topic Psychological Conditions
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10471420/
https://www.ncbi.nlm.nih.gov/pubmed/37662879
work_keys_str_mv AT kotsopoulosnikolaos assessingtheeconomicburdenandbenefitcostoftreatingattentiondeficithyperactivitydisorderingermany
AT connollymarkp assessingtheeconomicburdenandbenefitcostoftreatingattentiondeficithyperactivitydisorderingermany
AT sobanskiesther assessingtheeconomicburdenandbenefitcostoftreatingattentiondeficithyperactivitydisorderingermany
AT postmamaartenj assessingtheeconomicburdenandbenefitcostoftreatingattentiondeficithyperactivitydisorderingermany